Neo APAC Hackathon Kicks Off at Tokyo GAS Station Uncovering Local Web3 Talents and Empowering Regional Development
NEO Stock | USD 14.21 0.23 1.65% |
About 67 percent of all NeoGenomics' investors are curious in acquiring. The analysis of overall sentiment of trading NeoGenomics stock suggests that quite a few investors are confidant at this time. NeoGenomics' investing sentiment overview a quick insight into current market opportunities from investing in NeoGenomics. Many technical investors use NeoGenomics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
NeoGenomics |
PRESS RELEASE. Neo, the open-source, community-driven blockchain platform where developers are building the future Smart Economy, today announces the
Read at news.bitcoin.com
NeoGenomics Current Investor Sentiment
Panic Vs Confidence
67
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use NeoGenomics' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward NeoGenomics.
News SentimentBullish | Hype SentimentBullish | Insider SentimentDisposing |
NeoGenomics Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards NeoGenomics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
NeoGenomics Historical Investor Sentiment
Investor biases related to NeoGenomics' public news can be used to forecast risks associated with an investment in NeoGenomics. The trend in average sentiment can be used to explain how an investor holding NeoGenomics can time the market purely based on public headlines and social activities around NeoGenomics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
NeoGenomics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for NeoGenomics and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average NeoGenomics news discussions. The higher the estimate score, the more favorable the investor's outlook on NeoGenomics.
NeoGenomics Fundamental Analysis
We analyze NeoGenomics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NeoGenomics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NeoGenomics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Profit Margin
Profit Margin Comparative Analysis
NeoGenomics is currently under evaluation in profit margin category among its peers. Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
NeoGenomics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with NeoGenomics stock to make a market-neutral strategy. Peer analysis of NeoGenomics could also be used in its relative valuation, which is a method of valuing NeoGenomics by comparing valuation metrics with similar companies.
Peers
NeoGenomics Related Equities
TWST | Twist Bioscience | 3.68 | ||||
ACRS | Aclaris Therapeutics | 2.39 | ||||
SHC | Sotera Health | 2.29 | ||||
BDSX | Biodesix | 0.88 | ||||
QGEN | Qiagen NV | 0.22 | ||||
MTD | Mettler Toledo | 0.00 | ||||
IQV | IQVIA Holdings | 0.15 | ||||
NEOG | Neogen | 0.34 | ||||
CSTL | Castle Biosciences | 0.60 | ||||
MYGN | Myriad Genetics | 1.04 | ||||
CRL | Charles River | 1.39 | ||||
GH | Guardant Health | 1.74 | ||||
ICLR | ICON PLC | 2.15 | ||||
CDNA | Caredx | 2.81 | ||||
NTRA | Natera | 6.02 |
Check out NeoGenomics Hype Analysis, NeoGenomics Correlation and NeoGenomics Performance. To learn how to invest in NeoGenomics Stock, please use our How to Invest in NeoGenomics guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NeoGenomics. If investors know NeoGenomics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NeoGenomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.306 | Earnings Share (0.61) | Revenue Per Share | Quarterly Revenue Growth 0.104 | Return On Assets |
The market value of NeoGenomics is measured differently than its book value, which is the value of NeoGenomics that is recorded on the company's balance sheet. Investors also form their own opinion of NeoGenomics' value that differs from its market value or its book value, called intrinsic value, which is NeoGenomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NeoGenomics' market value can be influenced by many factors that don't directly affect NeoGenomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NeoGenomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if NeoGenomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeoGenomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.